NCT07104656 Bony Overlap Following Use of the Inferior Border Saw for the 'Low and Short' Sagittal Split: A Split-Mouth Study
| NCT ID | NCT07104656 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alabama at Birmingham |
| Condition | Mandibular Surgery |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-01-07 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-01-07 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate if use of an inferior border saw while making the inferior border osteotomy is associated with the medial cortex fracture pattern.
Eligibility Criteria
Inclusion Criteria: * patient's having mandible surgery Exclusion Criteria: * Severe dentofacial deformity secondary to a syndromic diagnosis
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07104656 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 75 Years, studying Mandibular Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07104656 currently recruiting?
Yes, NCT07104656 is actively recruiting participants. Contact the research team at briankinard@uabmc.edu for enrollment information.
Where is the NCT07104656 trial being conducted?
This trial is being conducted at Birmingham, United States.
Who is sponsoring the NCT07104656 clinical trial?
NCT07104656 is sponsored by University of Alabama at Birmingham. The trial plans to enroll 40 participants.